Hancock Whitney’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,684
Closed -$952K 911
2019
Q2
$952K Buy
5,684
+1,394
+32% +$193K 0.03% 469
2019
Q1
$628K Buy
4,290
+872
+26% +$126K 0.02% 564
2018
Q4
$457K Sell
3,418
-1,840
-35% -$302K 0.02% 616
2018
Q3
$1M Buy
+5,258
New +$966K 0.03% 478
2013
Q4
Sell
-98,650
Closed -$14.2M 552
2013
Q3
$14.2M Sell
98,650
-18,635
-16% -$2.48M 0.65% 40
2013
Q2
$14.8M Buy
+117,285
New +$13.3M 0.74% 35

Other funds holding AGN

Hancock Whitney's AGN Position: Q3 2019 in Review

Hancock Whitney sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 5,684 shares — an estimated $952K sold.

Hancock Whitney first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $14.8M in Q2 2013. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Hancock Whitney reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Hancock Whitney sold 5,684 Allergan plc shares in Q3 2019, an estimated $952K.
  • Hancock Whitney first reported a position in Allergan plc in Q2 2013 and held it in 6 quarters.
  • Hancock Whitney's Allergan plc position peaked at $14.8M in Q2 2013.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Hancock Whitney's 13F filing for Q3 2019, filed 29 Oct 2019.